Riverbridge Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Riverbridge Partners’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-603,899	Closed	-$12.2M	–	137
2018 Q1	$12.2M	Sell	603,899 -644,542	-52%	-$15M	0.22%	89
2017 Q4	$25.1M	Sell	1,248,441 -86,343	-6%	-$1.7M	0.48%	71
2017 Q3	$27.6M	Sell	1,334,784 -78,161	-6%	-$1.32M	0.54%	67
2017 Q2	$20.9M	Sell	1,412,945 -51,341	-4%	-$856K	0.4%	82
2017 Q1	$23.4M	Sell	1,464,286 -17,142	-1%	-$247K	0.47%	71
2016 Q4	$18.7M	Buy	1,481,428 +621,492	+72%	+$11.6M	0.39%	78
2016 Q3	$24.1M	Buy	859,936 +155,151	+22%	+$5.21M	0.48%	68
2016 Q2	$24.7M	Buy	704,785 +103,385	+17%	+$3.25M	0.51%	66
2016 Q1	$16.5M	Sell	601,400 -6,796	-1%	-$200K	0.34%	80
2015 Q4	$20.8M	Buy	+608,196	New	+$19M	0.43%	70

Other funds holding DPLO

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Riverbridge Partners's DPLO Position: Q2 2018 in Review

Riverbridge Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 603,899 shares — an estimated $12.2M sold.

Riverbridge Partners first reported a position in DPLO in Q4 2015 and held it in 10 quarters. The position peaked at $27.6M in Q3 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

Riverbridge Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
Riverbridge Partners sold 603,899 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $12.2M.
Riverbridge Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 10 quarters.
Riverbridge Partners's DIPLOMAT PHARMACY, INC. position peaked at $27.6M in Q3 2017.
206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Riverbridge Partners's 13F filing for Q2 2018, filed 3 Jul 2018.